Pakikoroid Pigment Epitelyopati; Bulgular, Tanı ve Yaklaşım

Pakikoroid (eski Yunanca’da paki: kalın) kalın koroid anlamına gelmektedir. Pakikoroid pigment epitelyopati (PPE) santral seröz koryoretinopatinin (SSKR) sınırlı kalmış formu olarak tanımlanmıştır. PPE’nin karakteristik özellikleri pakikoroid fenotipi ve retina pigment epiteli değişiklikleri olması, subretinal sıvı veya subretinal sıvı öyküsü olmamasıdır. PPE’den SSKR ve pakikoroid neovaskülopati gelişebilir. Bu derlemede PPE patogenezi, bulguları, klinik seyri, tanısı ve bu tabloya yaklaşımdan bahsedilmektedir

Pachychoroid Pigment Epitheliopathy; Signs, Diagnosis, and Management

Pachychoroid (ancient Greek pachy: thick) means thick choroid. Pachychoroid pigment epitheliopathy (PPE) has been recently defined as forme fruste of central serous chorioretinopathy (CSC). Its characteristic findings are pachychoroid phenotype, a variety of RPE abnormalities, absence of subretinal flid and absence of a history of subretinal flid. PPE may progress to CSC or pachychoroid neovasculopathy. Th aim of the current review is to provide an overview of signs, diagnosis, and management of PPE

Kaynakça

1. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126-145.

2. Gupta P, Gupta V, Dogra MR, Singh R, Gupta A. Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffcted eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol. 2010;30(2):175-181.

3. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29(10):1469-1473.

4. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 2011;31(8):1603-1608.

5. Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina 2013;33(8):1659-72.

6. Akkaya S. Spectrum of pachychoroid diseases. Int Ophthalmol. 2018;38(5):2239-2246.

7. Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, Mrejen S, Freund KB. Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol. 2014;3(4):111-115.

8. Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face Resim 4. Santral seröz koryoretinopatili bir gözün optik koherens tomografi ile iki yıllık izlemi. A. Aktif hastalık dönemi. B. Subretinal sıvı çekildikten üç ay sonra elipsoid zon intakt olmasına rağmen beyaz oklar arasındaki bölgede interdigitasyon zonu izlenmiyor. C. Subretinal sıvı çekildikten iki yıl sonra interdigitasyon zonu büyük oranda tekrar oluşmasına rağmen hala beyaz oklar arasındaki bölgede interdigitasyon zonu izlenmiyor. imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 2016;36(3):499-516.

9. Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol. 2015;160(6):1243-1254.

10. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33(1):14-33.

11. Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I. Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy. Br J Ophthalmol. 2018;102(4):473-478.

12. Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I. Outer nuclear layer thinning in pachychoroid pigment epitheliopathy. Retina. 2018;38(5):957-961.

13. Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Indocyanine green angiography of pachychoroid pigment epitheliopathy. Retina. 2018;38(9):1668-1674.

14. Karacorlu M, Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I. Longterm follow-up of pachychoroid pigment epitheliopathy and lesion characteristics. Graefes Arch Clin Exp Ophthalmol. 2018;256(12):2319- 2326.

15. Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol. 2018 doi: 10.1136/ bjophthalmol-2018-312431.

16. Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P.et al. Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study. Curr Eye Res 2017;42(7):1069-1073.

17. Ersoz MG, Hocaoglu M, Sayman Muslubas I, Arf S, Karacorlu M. Development of pachychoroid pigment epitheliopathy and transformation to central serous chorioretinopathy aftr intravitreal dexamethasone implantation. Retin Cases Brief Rep. 2018. doi: 10.1097/ ICB.0000000000000820.

18. Ersoz MG, Arf S, Karacorlu M, Hocaoglu M, Muslubas IS. Pachychoroid Pigment Epitheliopathy Associated With Tamoxifen. Ophthalmic Surg Lasers Imaging Retina. 2017;48(10):838-842.

19. Bolukbasi S, Erden B, Cakir A, Bayat AH, Elcioglu MN, Yurttaser Ocak S. Pachychoroid Pigment Epitheliopathy and Choroidal Thckness Changes in Coeliac Disease. J Ophthalmol. 2019. doi: 10.1155/2019/6924191

20. Goldstein BG, Pavan PR. ‘Blow-outs’ in the retinal pigment epithelium. Br J Ophthalmol. 1987;71(9):676-681.

21. Ober MD, Eandi CM, Jampol LM, Fine HF, Yannuzzi LA. Focal retinal pigment epithelium breaks in central serous chorioretinopathy. Retin Cases Brief Rep. 2007;1(4):271-3.

22. Roberts P, Baumann B, Lammer J, Gerendas B, Kroisamer J, Bühl W, ve ark. Retinal pigment epithelial features in central serous chorioretinopathy identified by polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2016;57(4):1595-1603.

23. Gupta V, Gupta P, Dogra MR, Gupta A. Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy. Eye (Lond). 2010;24(4):595-599.

24. Gal-Or O, Dansingani KK, Sebrow D, Dolz-Marco R, Freund KB. Inner choroidal flw signal attenuation in pachychoroid disease: optical coherence tomography angiography. Retina. 2018;38(10):1984-1992.

25. Rochepeau C, Kodjikian L, Garcia MA, Coulon C, Burillon C, Denis P, ve ark. Optical coherence tomography angiography quantitative assessment of choriocapillaris blood flw in central serous chorioretinopathy. Am J Ophthalmol. 2018;194:26-34.

26. Baek J, Kook L, Lee WK. Choriocapillaris flw impairments in association with pachyvessel in early stages of pachychoroid. Sci Rep. 2019;9(1):5565.

27. Lee JH, Kim JY, Jung BJ, Lee WK. Focal disruptions in ellipsoid zone and interdigitation zone on spectral-domain optical coherence tomography in pachychoroid pigment epitheliopathy. Retina. 2018 doi: 10.1097/ IAE.0000000000002187.

28. Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina. 2018;38(4):708-716.

29. Matsumoto H, Mukai R, Morimoto M, Tokui S, Kishi S, Akiyama H. Clinical characteristics of pachydrusen in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2019. doi: 10.1007/s00417-019- 04284-4.

30. Baek J, Lee JH, Chung BJ, Lee K, Lee WK. Choroidal morphology under pachydrusen. Clin Exp Ophthalmol. 2018. doi: 10.1111/ceo.13438.

31. Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32(9):1829- 1837.

32. Lee M, Lee H, Kim HC, Chung H. Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases. Invest Ophthalmol Vis Sci. 2018;59:4896-4908.

33. van Dijk EH, Duits DE, Versluis M, Luyten GP, Bergen AA, Kapiteijn EW, ve ark. Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients. Medicine (Baltimore). 2016;95(18):e3457.

Kaynak Göster